United States3 robots tracked

Intuitive

Intuitive makes 3 robots we track. The furthest along, da Vinci 5, is at stage 5 of 5: regulator-cleared or mass market.

Website: intuitive.com
Based in: United States
Latest milestone: 21 Oct 2026

01Robots

What Intuitive makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

da Vinci 5Medical · Multi-arm surgical robotStage 5 of 5 · Regulator-cleared or mass marketda Vinci 5 is Intuitive's newest surgical robot with several arms. A surgeon at a console moves the arms to do keyhole surgery through small cuts.Sold to hospitals in the US and, since July 2025, in Europe. Intuitive placed 246 of them in the second quarter of 2026.The full record
da Vinci SPMedical · Single-port surgical robotStage 5 of 5 · Regulator-cleared or mass marketda Vinci SP is a surgical robot that works through one small cut, or through a natural opening such as the mouth, instead of several cuts. Its camera and instruments come out of a single tube.Sold to hospitals in the US since 2018 and in other countries, including Korea. About 95 of the roughly 1,790 da Vinci robots Intuitive placed in 2024 were SP systems.The full record
IonMedical · Lung biopsy robotStage 5 of 5 · Regulator-cleared or mass marketIon is a robot that steers a very thin, flexible tube down the airways into the lungs. Doctors use it to take small tissue samples (biopsies) from spots in the lung that may be cancer.In hospitals in 10 countries. Intuitive reported 1,096 Ion systems installed as of 30 June 2026.The full record

02Track record

Every dated event

21 Oct 2026Milestoneda Vinci 5
Intuitive said it placed 315 da Vinci 5 systems in the third quarter of 2026, up from 240 a year earlier.
MedTech Dive, 21 Oct 2026Company-reported
16 July 2026Milestoneda Vinci 5
Intuitive placed 246 da Vinci 5 systems with hospitals in the second quarter of 2026, up from 180 a year earlier.
Intuitive Q2 2026 results, 16 July 2026Company-reported
16 July 2026MilestoneIon
Intuitive placed 55 Ion systems in the second quarter of 2026, up from 54 a year earlier.
Intuitive Q2 2026 results, 16 July 2026Company-reported
19 Feb 2026Safetyda Vinci SP
Two professors filed a petition asking the FDA to remove the robotic mastectomy use until long-term cancer safety data exist.
Northeastern University School of Law, 19 Feb 2026
26 Jan 2026Regulatorda Vinci 5
The FDA cleared da Vinci 5 for certain heart operations, such as mitral valve repair, done through small cuts between the ribs.
Intuitive press release, 26 Jan 2026Company-reported
15 Dec 2025Regulatorda Vinci SP
Under 510(k) clearance K252675, the FDA cleared da Vinci SP for nipple-sparing mastectomy, a breast cancer operation.
Citizen petition to FDA, Feb 2026
10 Dec 2025Regulatorda Vinci SP
The FDA cleared da Vinci SP for groin hernia repair, gallbladder removal and appendix removal.
MedTech Dive, 11 Dec 2025
7 Nov 2025Safetyda Vinci 5
Intuitive started a Class 2 recall covering da Vinci X, Xi and da Vinci 5. A software error let instrument arms that failed a safety self-test stay in use.
FDA recall database, initiated 7 Nov 2025
8 Oct 2025RegulatorIon
The FDA cleared new Ion software, including AI and imaging features, which Intuitive planned to release through a limited launch.
MassDevice, 8 Oct 2025Company-reported
2 July 2025Milestoneda Vinci 5
da Vinci 5 received the CE mark, which allows it to be sold in Europe, for adults and children.
MassDevice, 2 July 2025
30 June 2025MilestoneIon
Intuitive said more than 900 Ion systems were in hospitals across 10 countries.
MassDevice, 8 Oct 2025Company-reported
12 May 2025Safetyda Vinci SP
Intuitive started a Class 2 recall of SP instrument arm drapes (sterile covers), which could come loose from the robot arm.
FDA recall database, initiated 12 May 2025
May 2025Regulatorda Vinci SP
The FDA cleared da Vinci SP for colorectal (bowel) surgery.
MassDevice, 2 July 2025
2025Milestoneda Vinci 5
Intuitive began its full commercial rollout of da Vinci 5 in the US in 2025.
MassDevice, 2 July 2025
21 March 2024MilestoneIon
China's medical device regulator approved Ion for sale in China.
MassDevice, 21 Mar 2024
14 March 2024Milestoneda Vinci 5
Intuitive said da Vinci 5 would first go to a small number of US customers before a wider launch.
Intuitive press release (SEC filing), 14 Mar 2024Company-reported
14 March 2024Regulatorda Vinci 5
The FDA cleared da Vinci 5 through the 510(k) route.
MassDevice, 15 Mar 2024
28 April 2023Regulatorda Vinci SP
The FDA cleared da Vinci SP for more prostate operations, including removal of the whole prostate through the bladder.
MassDevice, 28 Apr 2023
23 Oct 2020SafetyIon
Intuitive started a Class 2 recall of an Ion catheter because a ring at its tip could come off during a procedure.
FDA recall database, initiated 23 Oct 2020
March 2019Regulatorda Vinci SP
The FDA cleared da Vinci SP for ear, nose and throat surgery done through the mouth.
MedTech Dive, 18 Mar 2019
19 Feb 2019MilestoneIon
Intuitive said it would roll Ion out slowly in the US, with the first shipments to customers in the second quarter of 2019.
MedTech Dive, 20 Feb 2019Company-reported
19 Feb 2019RegulatorIon
The FDA cleared Ion for taking biopsies from the outer parts of the lung.
MedTech Dive, 20 Feb 2019
May 2018Regulatorda Vinci SP
The FDA first cleared da Vinci SP for urology operations, such as on the prostate and bladder.
MedTech Dive, 18 Mar 2019

03Money

On the stock market

Intuitive trades as ISRG on NASDAQ. Intuitive second-quarter 2026 results, 16 July 2026

All robot stocks, funding and suppliers

Prices by TradingView, about 15 minutes delayed. Not investment advice.